Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers

NCT01153997 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Bleeding Disorder
Cardiac Surgery Requiring Cardiopulmonary Bypass
Healthy

Interventions

DRUG: catridecacog
DRUG: placebo
DRUG: catridecacog
DRUG: placebo

Sponsor

Novo Nordisk A/S